Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Yellowing, browning, or visible particulate in a reconstituted solution are signs of degradation or contamination
If you plan to start retatrutide treatment, consult your healthcare professional first to discuss whether it is the right choice for you
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
For Professional Use Only
Bangkok Peptides supplies 5 Amino-1-MQ locally within Thailand to support research environments requiring consistent, high-quality sourcing
